Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, International, Multi-center, Open-label Study to Document Pharmacokinetics and Optimal Timing of Initiation of Dronedarone Treatment Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation Whatever the Reason for the Change of Treatment.

NCT01199081 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01199081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, International, Multi-center, Open-label Study to Document Pharmacokinetics and Optimal Timing of Initiation of Dronedarone Treatment Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation Whatever the Reason for the Change of Treatment.
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
April 30, 2012
Enrollment
154 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation